Campylobacter culture fails to correctly detect Campylobacter in 30% of positive patient stool specimens compared to non-cultural methods
To read the full manuscript, click here… Continue reading
NEWS
What we are up to:
TECHLAB COO Robert Day elected to the board of Virginia Bio
TECHLAB Chief Operating Officer Robert Day has been elected to the board of Virginia Bio, the premier statewide non-profit association representing the life science industry in Virginia. Congratulations, Rob! Read the full article her… Continue reading
Dr. Bincy P. Abraham explains the benefits of fecal lactoferrin
Gastroenterology & Hepatology recently featured an interview with Dr. Bincy P. Abraham, Director of the Gastroenterology Fellowship Program at Houston Methodist. Dr. Abraham explains the benefits of fecal lactoferrin testing and how lactoferrin testing can help manage patients with IBD. Read the entire interview here… Continue reading
H. pylori webinar presented by Dr. David Lyerly
Join us for a webinar exploring H. pylori diagnosis and considerations for selecting the appropriate testing methodology. Click here to watch the archived version. … Continue reading
TECHLAB featured as a leader in infectious disease diagnostics
TECHLAB was recently featured on the website of the Valleys Innovation Council. Check out the article at https://www.valleysinnovation.org/techlab/ &nbs… Continue reading
TECHLAB participates in VT Corporate Research Center Media Day
On Tuesday, September 17, TECHLAB participated in the Virginia Tech Corporate Research Center’s Media Day event. We welcomed media representatives to TECHLAB to learn about our company history, the science behind our products, and our plans to grow in the future. CEO Dan Delaney and COO Rob Day explained that TECHLAB was founded in 1989 … Continue reading
PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance to Market H. PYLORI QUIK CHEK™ and H. PYLORI CHEK™ Tests
BLACKSBURG, Va. – Aug. 21, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the H. PYLORI QUIK CHEK™ and the H. PYLORI CHEK™ tests. Both are designed to aid in the diagnosis of H. … Continue reading
PRESS RELEASE: TECHLAB® Products Identified As Meeting Updated Clinical Practice Guidelines For Clostridium Difficile Infection
BLACKSBURG, Va. – Feb. 26, 2018 – TECHLAB®, Inc., today announced its products meet the updated Clinical Practice Guidelines for Clostridium difficile from The Infectious Disease Society of America (IDSA) and the Society of Healthcare Epidemiology of America (SHEA). The new recommendations recently published in the journal Clinical Infectious Diseases, emphasize the value of immunoassay toxin … Continue reading
PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance to Market CAMPYLOBACTER QUIK CHEK™ and CAMPYLOBACTER CHEK™ Tests
BLACKSBURG, Va. – January 23, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the CAMPYLOBACTER QUIK CHEK™ and the CAMPYLOBACTER CHEK™ tests. Both are intended to aid diagnosis of campylobacteriosis, one of the most common … Continue reading
PRESS RELEASE: Phoenix Lab to Offer GIARDIA VET CHEK™ From TECHLAB®
BLACKSBURG, Va. and MUKILTEO, Wash. – January 11, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received a USDA establishment license and product license for GIARDIA VET CHEK™. The test qualitatively detects Giardia cyst antigen in canine and feline fecal samples and is the … Continue reading
